Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 25,650
+55 (0.21%)
Jun 25, 2026, 3:30 PM IST
Abbott India Market Cap
Abbott India has a market cap or net worth of 543.79 billion as of June 26, 2026. Its market cap has decreased by -19.27% in one year.
Market Cap
543.79B
Enterprise Value
521.65B
Revenue
69.29B
Ranking
n/a
PE Ratio
35.04
Stock Price
25,650.00
Market Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 543.79B, an increase of 11,301.95%. That is a compound annual growth rate of 21.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 543.79B | -11.97% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.10T |
| Mankind Pharma | 1.02T |
| Aurobindo Pharma | 894.83B |
| Laurus Labs | 782.79B |
| Alkem Laboratories | 648.64B |
| Glenmark Pharmaceuticals | 607.97B |
| Ipca Laboratories | 410.57B |
| Ajanta Pharma | 397.19B |